315 related articles for article (PubMed ID: 16514472)
1. The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica.
Ceccato F; Roverano S; Barrionuevo A; Rillo O; Paira S
Clin Rheumatol; 2006 Nov; 25(6):854-7. PubMed ID: 16514472
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica.
Lopez-Hoyos M; Ruiz de Alegria C; Blanco R; Crespo J; Peña M; Rodriguez-Valverde V; Martinez-Taboada VM
Rheumatology (Oxford); 2004 May; 43(5):655-7. PubMed ID: 14970400
[TBL] [Abstract][Full Text] [Related]
3. Early recognition improves prognosis in elderly onset RA.
Negoescu A; Ostör AJ
Practitioner; 2014 Jan; 258(1767):11-4, 2. PubMed ID: 24617098
[TBL] [Abstract][Full Text] [Related]
4. Cytidine deaminase in polymyalgia rheumatica and elderly onset rheumatoid arthritis.
Paira S; Roverano S; Rillo O; Barrionuevo A; Mahieu S; Millen N
Clin Rheumatol; 2005 Sep; 24(5):460-3. PubMed ID: 15666033
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
6. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
Chang PY; Yang CT; Cheng CH; Yu KH
Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease.
Chen DY; Hsieh TY; Chen YM; Hsieh CW; Lan JL; Lin FJ
Gerontology; 2009; 55(3):250-8. PubMed ID: 18849599
[TBL] [Abstract][Full Text] [Related]
9. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
10. The clinical course of polymyalgia rheumatica in Chinese.
Li WL; Lo Y; Leung MH; Wong WS; Mok MY
Clin Rheumatol; 2010 Feb; 29(2):199-203. PubMed ID: 19915991
[TBL] [Abstract][Full Text] [Related]
11. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
12. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis].
Cho SY; Kang SY; Lee HJ; Lee WI
Korean J Lab Med; 2008 Feb; 28(1):39-45. PubMed ID: 18309254
[TBL] [Abstract][Full Text] [Related]
13. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
14. Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort.
Mouterde G; Lukas C; Goupille P; Flipo RM; Rincheval N; Daurès JP; Combe B
J Rheumatol; 2014 Aug; 41(8):1614-22. PubMed ID: 25028372
[TBL] [Abstract][Full Text] [Related]
15. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis.
Sulli A; Montecucco CM; Caporali R; Cavagna L; Montagna P; Capellino S; Fazzuoli L; Seriolo B; Alessandro C; Secchi ME; Cutolo M
Ann N Y Acad Sci; 2006 Jun; 1069():307-14. PubMed ID: 16855158
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic significance of combined detection of rheumatoid factor and anticyclic citrullinated peptide antibodies in rheumatoid arthritis].
Mu R; Sun XY; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):498-500. PubMed ID: 16224521
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of third generation anti-CCP antibodies in the diagnosis of rheumatoid arthritis from undifferentiated polyarthritis after 4 years of follow-up.
Caro-Oleas JL; Fernández-Suárez A; Reneses Cesteros S; Porrino C; Núñez-Roldán A; Wichmann Schlipf I
Clin Exp Rheumatol; 2008; 26(3):461-3. PubMed ID: 18578970
[TBL] [Abstract][Full Text] [Related]
19. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
